Atea Pharmaceuticals, Inc. (AVIR) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Atea Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
  • Atea Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$259 M, a 172% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$259 M -$164 M -172% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$196 M -$136 M -227% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 -$157 M -$131 M -516% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$124 M -$106 M -611% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$95.3 M -$109 M -783% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$59.9 M -$116 M -207% Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$25.4 M +$35.7 M +58.4% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$17.4 M +$15.5 M +47.2% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $14 M +$48.4 M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $56 M +$121 M Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$61.1 M +$24.7 M +28.8% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$32.9 M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$34.4 M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$65.2 M -$10.9 M -20.2% Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$85.8 M Sep 30, 2020 10-Q 2020-12-10
Q4 2019 -$54.2 M Dec 31, 2019 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.